NCT02345590View on ClinicalTrials.gov

Eplerenone in the Management of Abdominal Aortic Aneurysms

PHASE4UnknownINTERVENTIONAL

Enrollment

172

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions

Aortic Aneurysm, Abdominal

Interventions

DRUG

Eplerenone

25mg of eplerenone

Trial Locations (2)

3000

RECRUITING

Baker IDI, Melbourne

3004

RECRUITING

Heart Centre, Alfred Health, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Baker Heart and Diabetes Institute

OTHER

lead

Bayside Health

OTHER_GOV